Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
North America is expected to hold a significant share in the overall market growth of diabetic ulcer treatment. This can be associated with a large percentage of geriatric population, huge investments into research and drug development (R&D) projects, and the growth of the healthcare sector in the region. In addition to this, the sedentary lifestyles and unhealthy eating habits of the people are a leading cause of diabetes in the region, which is growing at an alarming rate, hence necessitating the introduction of an advanced treatment. Apart from this, the launch of highly advanced wound care dressings for the treatment of foot ulcers and the increasing adoption of these treatments by hospitals in the North American region is anticipated to boost the market growth in the region.
RLS Global AB, a significant player in the global market for diabetic ulcer treatment, recently received regulatory approval for ChloraSolv developed for the treatment of foot ulcers in New Zealand in August 2021. ChloraSolv, known for its unique properties, is expected to deliver positive results with patients suffering from foot ulcers caused by diabetes. With this approval, RLS has established a first market presence in Oceania and is expected to broaden its presence in the market in the coming years. Such developments by market players and the expansion strategies employed by industry players like Medtronic Plc (NYSE: MDT) are leading the growth of the market.
Market Analysis by Treatment Type, Grade, End User, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global diabetic ulcer treatment market are ConvaTec Group plc, Acelity L.P. Inc., 3M Company, Smith and Nephew Plc., B. Braun Melsungen Ag, Medline Industries, LP, Medtronic Plc, Organogenesis Holdings Inc, Molnlycke Health Care AB, and BSN Medical GMBH, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.